These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9607389)

  • 21. Losartan vs atenolol in prevention of stroke and cardiovascular disease.
    Messerli FH; Grossman E; Fournier A
    JAMA; 2003 Feb; 289(6):700-1; author reply 701. PubMed ID: 12585945
    [No Abstract]   [Full Text] [Related]  

  • 22. C-reactive protein elevation predicts pulse pressure reduction in hypertensive subjects.
    Amar J; Ruidavets JB; Peyrieux JC; Mallion JM; Ferrières J; Safar ME; Chamontin B
    Hypertension; 2005 Jul; 46(1):151-5. PubMed ID: 15956115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
    Bönner G; Schmieder R; Chrosch R; Weidinger G
    Cardiovasc Drugs Ther; 1997 Mar; 11(1):21-6. PubMed ID: 9140673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression of left ventricular wall thickness during ACE-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow.
    Andersson PE; Lind L; Andrén B; Hänni A; Reneland R; Berne C; Lithell H
    Blood Press; 1998 May; 7(2):118-26. PubMed ID: 9657539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the efficacy and safety of fosinopril in general practice in 19,435 hypertensive patients (FLIGHT Study)].
    Berdah J; Guest M; Salvador M
    Ann Cardiol Angeiol (Paris); 1998 Mar; 47(3):169-75. PubMed ID: 9772944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
    Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
    Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
    J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.
    Alli C; Lombardo M; Zanni D; Agrati AM; Cassani M; Granata S
    Am J Hypertens; 1996 Nov; 9(11):1068-76. PubMed ID: 8931831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia].
    Vershinina AM; Gapon LI; Veber EE; Popova SN; Pliusnin AV
    Ter Arkh; 2005; 77(4):55-8. PubMed ID: 15938534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.
    Schneider MP; Klingbeil AU; Delles C; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE
    Hypertension; 2004 Jul; 44(1):61-6. PubMed ID: 15184349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive therapy in type 2 diabetes mellitus.
    Miser WF
    J Fam Pract; 1998 Dec; 47(6):413-4. PubMed ID: 9866657
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertension in the elderly.
    Martin ME
    Cleve Clin J Med; 2000 Jan; 67(1):68. PubMed ID: 10645680
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients.
    Tiryaki O; Usalan C; Buyukhatipoglu H
    Nephrology (Carlton); 2010 Mar; 15(2):211-5. PubMed ID: 20470281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.
    Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvänen AC; Lind L; Kahan T
    Am J Hypertens; 2008 Jul; 21(7):836-9. PubMed ID: 18464745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.